Insight

Industrial Purity 9-Bromo-10-Phenylanthracene ≥99% Assay: Technical Assurance for High-Performance OLED Manufacturing

  • ≥99% assay purity verified by GC/HPLC with full COA documentation for traceable quality control.
  • Optimized synthesis route minimizes halogenated byproducts that degrade OLED emission layer performance.
  • Bulk supply of 9-Bromo-10-phenylanthracene from NINGBO INNO PHARMCHEM CO.,LTD. meets global industrial demand with consistent industrial purity.

In the rapidly evolving field of organic light-emitting diodes (OLEDs), the performance and longevity of emissive layers depend critically on the chemical integrity of key intermediates. Among these, 9-Bromo-10-phenylanthracene (CAS: 23674-20-6) serves as a foundational building block for blue-emitting materials due to its rigid anthracene core and tunable electronic properties. However, even minor impurities—particularly residual isomers like 10-bromo-9-phenylanthracene or unreacted starting materials—can significantly reduce electroluminescence efficiency and accelerate device degradation. This underscores the necessity of sourcing material with rigorously controlled industrial purity and a verified assay of ≥99%.

Analytical Methods for Purity Verification

Accurate quantification of 9-Bromo-10-phenylanthracene purity requires orthogonal analytical techniques to distinguish it from structurally similar regioisomers such as bromo-9 phenyl-10 anthracene or 9-phenyl-10-bromoanthracene. At NINGBO INNO PHARMCHEM CO.,LTD., every batch undergoes a dual-validation protocol:

  • Gas Chromatography (GC) with FID detection for volatile impurity screening.
  • High-Performance Liquid Chromatography (HPLC) using C18 reverse-phase columns for non-volatile and isomeric separation.

Coupled with mass spectrometry (GC-MS/LC-MS), this approach enables precise identification of trace contaminants down to 0.1%. Each shipment includes a comprehensive Certificate of Analysis (COA) detailing assay results, residual solvent levels (per ICH Q3C), and heavy metal content (per USP <232>/<233>), ensuring compliance with ISO 9001 and REACH standards.

Impact of ≥99% Assay on OLED Yield Consistency

The transition from laboratory-scale (≥98%) to industrial-grade (≥99%) purity is not merely incremental—it is transformative for manufacturing economics. In OLED fabrication, impurities in the host or dopant matrix can act as exciton quenchers or charge traps, leading to:

  • Reduced external quantum efficiency (EQE)
  • Increased driving voltage
  • Premature luminance decay

Studies have shown that elevating the assay of Anthracene 9-Bromo-10-phenyl from 98% to ≥99% improves device lifetime by up to 35% under constant-current operation. This consistency is achieved through a refined synthesis route that avoids Friedel-Crafts side reactions and employs selective bromination at the C9 position under inert atmosphere, minimizing dibrominated byproducts.

Impurity Profiling and Acceptance Criteria

For industrial adoption, impurity thresholds must be defined not just by total area percent, but by functional impact. NINGBO INNO PHARMCHEM CO.,LTD. classifies impurities in 9-Bromo-10-phenylanthracene into three tiers:

Impurity Type Acceptance Limit (≤) Analytical Method
Regioisomers (e.g., 10-bromo-9-phenylanthracene) 0.3% HPLC-UV @ 254 nm
Residual Solvents (Toluene, DMF) 500 ppm GC-FID
Heavy Metals (Pb, Cd, Hg) 10 ppm total ICP-MS

This stringent profiling ensures that the final product meets the exacting demands of vacuum thermal evaporation (VTE) processes used in AMOLED panel production. When sourcing high-purity 9-Bromo-10-phenylanthracene, buyers should prioritize suppliers with documented batch reproducibility and scalable manufacturing process validation.

Bulk Supply and Global Commercial Advantage

As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. offers industrial quantities of ≥99% assay 9-Bromo-10-phenylanthracene with lead times under 4 weeks. Our integrated production facility in China enables cost-efficient scale-up without compromising on purity—critical for clients evaluating bulk price against total cost of ownership in OLED stack fabrication.

With in-house R&D capabilities and GMP-aligned quality systems, we provide not just a chemical intermediate, but a reliability-engineered component that directly enhances yield stability in high-value optoelectronic manufacturing.